Type 2 Diabetes

Data suggest that personalizing therapy may ease the burden of diabetic complications and prevent diabetes in the future generation.

There is strong evidence that circulating markers of systemic inflammation can predict long-term cognitive decline among older people with type 2 diabetes.

Data analysis suggests that weight changes during weight loss attempts may raise the risk of cardiovascular disease and mortality in people with type 2 diabetes. 

The analysis of lipid profiling in the prediction of risk of developing type 2 diabetes and cardiovascular diseases can aid in recommending lifestyle changes and diet before the development of the diseases.

Studies have shown that emotional eating and other eating behaviors could reduce weight loss when taking GLP-1 receptor agonists.

According to the research presented by Dr. Petter Bjornstad from the University of Colorado Anschutz Medical Campus, the risk of microvascular complications increases by the time of young adulthood in patients who have diabetes in youth.

Data suggest that fewer than twenty percent of patients with type 2 diabetes are lowering their risk of heart disease, prompting prominent doctors to demand immediate action. 

There is growing evidence suggesting that the quality and duration of sleep may contribute to the risk of prediabetes progressing to type 2 diabetes.

A data-driven-approach study was conducted to identify the cost of spending for long-term care patients with diabetes by accessing data from Medicare Fee-for-Service beneficiaries, including Medicare parts A, B, and D for two years. 

Studies have found that there may be a connection between hormone therapy use and type 2 diabetes, putting transgender individuals at an increased risk.